title: [EXPERIENCE IN TREATING HELMINTHISM WITH MICRONIZED ALBENDAZOLE (GELMODOL)].
abstract: The paper gives the results of treatment with micronized albendazole (Gelmodol-BM, World Medicine, UK) in 87 patients of the Department of Medical Parasitology and Tropical Diseases, Clinical and Diagnostic Center, Clinical Center, I.M.Sechenov First Moscow State Medical University. Thirty-two patients with echinococcosis 8 with alveococcosis (including 4 inoperable patients), 10 with ascariasis, 10 with toxocariasis, 15 with enterobiasis, and 12 people diagnosed with larva migrans were treated in 2013-2014. The drug's routine doses and dosage regimens were used. Albendazole (Gelmodol, World Medicine, UK) showed a high efficacy with good tolerability, which is highly competitive with that of the drugs manufactured by IPCA Laboratories Ltd., India (such as nemozole). Both medicaments above-mentioned may be successfully used in the treatment of many helminthisms.
authors.forename: V D
authors.initials: VD
authors.lastname: Zavoikin
authors.forename: N I
authors.initials: NI
authors.lastname: Tumolskaya
authors.forename: M V
authors.initials: MV
authors.lastname: Mazmanyan
authors.forename: O P
authors.initials: OP
authors.lastname: Zelya
authors.forename: D V
authors.initials: DV
authors.lastname: Tikhonova
mesh_terms: D000293:Adolescent; D000368:Aged; D015766:Albendazole / Q000627:therapeutic use*; D000818:Animals; D001196:Ascariasis / Q000188:drug therapy / Q000469:parasitology; D002648:Child; D004443:Echinococcosis / Q000188:drug therapy* / Q000469:parasitology; D017229:Enterobiasis / Q000188:drug therapy* / Q000469:parasitology; D005260:Female; D006376:Helminths / Q000187:drug effects / Q000472:pathogenicity; D006801:Humans; D008297:Male; D008875:Middle Aged; D012426:Russia; D014120:Toxocariasis / Q000188:drug therapy* / Q000469:parasitology
chemical_list: D015766:Albendazole